Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Hoff

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Medical Oncology (Northwood, London, England)|October 3, 2014
Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenibLeonardo Gomes da Fonseca, Romulado Barroso-Sousa, Afonso da Silva Alves Bento, et al.
Rare Tumors|November 2, 2013
Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomasRodrigo Ramella Munhoz, Juliana Florinda de Mendonça Rego, Anezka Rubim de Celis Ferrari, et al.
Ecancermedicalscience|August 29, 2015
Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreasMaria Ignez Braghiroli, Anezka C R de Celis Ferrari, Tulio Eduardo Pfiffer, et al.
Journal of Global Oncology|December 16, 2017
Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival OutcomesRicardo Emanuel de Oliveira Ramos, Milena Perez Mak, Michel Fabiano Silva Alves, et al.
Infection Control and Hospital Epidemiology|February 11, 2022
Applying mucosal barrier injury laboratory-confirmed bloodstream infection criteria in patients with solid tumors and hematologic malignancies: A retrospective cohort study looking for the real source of infectionAna Carolina Puin da Silva, Michely Fernandes Vieira, Maristela Pinheiro Freire, et al.
JCO Global Oncology|August 12, 2021
Fluorouracil Bolus Use in Infusional Regimens Among Oncologists-A Survey by Brazilian Group of Gastrointestinal TumorsRenata D Peixoto, Anelisa K Coutinho, Rui Fernando Weschenfelder, et al.
Thyroid : Official Journal of the American Thyroid Association|December 25, 2015
Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety AnalysisLuciana Audi de Castroneves, Marcelo Vailati Negrão, Ricardo Miguel Costa de Freitas, et al.
Journal of Cancer|November 3, 2021
A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment OutcomesCamila Motta Venchiarutti Moniz, Rachel Pimenta Riechelmann, Suilane Coelho Ribeiro Oliveira, et al.
Ecancermedicalscience|September 29, 2017
Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancerJuliana Florinda de M Rêgo, Raphael Salles Scortegagna de Medeiros, Maria Ignez Braghiroli, et al.
JCO Global Oncology|July 30, 2025
Effectiveness and Safety of Immunotherapy for Hepatocellular Carcinoma in Clinical Practice: A Brazilian Multicenter StudyLeonardo Gomes da Fonseca, Cecília Souza Freire, Rodrigo Antonio Vieira Guedes, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Medical Oncology (Northwood, London, England)|October 3, 2014
Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenibLeonardo Gomes da Fonseca, Romulado Barroso-Sousa, Afonso da Silva Alves Bento, et al.
Rare Tumors|November 2, 2013
Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomasRodrigo Ramella Munhoz, Juliana Florinda de Mendonça Rego, Anezka Rubim de Celis Ferrari, et al.
Ecancermedicalscience|August 29, 2015
Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreasMaria Ignez Braghiroli, Anezka C R de Celis Ferrari, Tulio Eduardo Pfiffer, et al.
Journal of Global Oncology|December 16, 2017
Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival OutcomesRicardo Emanuel de Oliveira Ramos, Milena Perez Mak, Michel Fabiano Silva Alves, et al.
Infection Control and Hospital Epidemiology|February 11, 2022
Applying mucosal barrier injury laboratory-confirmed bloodstream infection criteria in patients with solid tumors and hematologic malignancies: A retrospective cohort study looking for the real source of infectionAna Carolina Puin da Silva, Michely Fernandes Vieira, Maristela Pinheiro Freire, et al.
JCO Global Oncology|August 12, 2021
Fluorouracil Bolus Use in Infusional Regimens Among Oncologists-A Survey by Brazilian Group of Gastrointestinal TumorsRenata D Peixoto, Anelisa K Coutinho, Rui Fernando Weschenfelder, et al.
Thyroid : Official Journal of the American Thyroid Association|December 25, 2015
Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety AnalysisLuciana Audi de Castroneves, Marcelo Vailati Negrão, Ricardo Miguel Costa de Freitas, et al.
Journal of Cancer|November 3, 2021
A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment OutcomesCamila Motta Venchiarutti Moniz, Rachel Pimenta Riechelmann, Suilane Coelho Ribeiro Oliveira, et al.
Ecancermedicalscience|September 29, 2017
Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancerJuliana Florinda de M Rêgo, Raphael Salles Scortegagna de Medeiros, Maria Ignez Braghiroli, et al.
JCO Global Oncology|July 30, 2025
Effectiveness and Safety of Immunotherapy for Hepatocellular Carcinoma in Clinical Practice: A Brazilian Multicenter StudyLeonardo Gomes da Fonseca, Cecília Souza Freire, Rodrigo Antonio Vieira Guedes, et al.
Pageof 3